Haruhiko Imamoto
- Gastroenterology top 1%
- Gastrointestinal Tumor Research and Treatment 21
-
- Gastric Cancer Management and Outcomes 37
- Metastasis and carcinoma case studies 13
- Lung Cancer Treatments and Mutations 6
- Surgery top 5%
- Esophageal Cancer Research and Treatment 15
- Intraperitoneal and Appendiceal Malignancies 12
- Esophageal and GI Pathology 9
- Cholangiocarcinoma and Gallbladder Cancer Studies 6
- Oncology top 10%
- Reproductive Medicine top 5%
- Co-authors
- Motohiro ImanoHitoshi ShiozakiTakushi YasudaMasayuki ShinkaiYing‐Feng PengHiroshi FurukawaAtsushi YasudaAtsushi Nashimoto
- Journals
- Journal of Clinical Oncology (9 papers)SHILAP Revista de lepidopterología (2 papers)Cancer (1 paper)
In The Last Decade
Haruhiko Imamoto
60 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 67
- Gastroenterology 341
- Pulmonary and Respiratory Medicine 893
- Surgery 842
- Oncology 368
- Reproductive Medicine 102
Countries citing papers authored by Haruhiko Imamoto
This map shows the geographic impact of Haruhiko Imamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruhiko Imamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruhiko Imamoto more than expected).
Fields of papers citing papers by Haruhiko Imamoto
This network shows the impact of papers produced by Haruhiko Imamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruhiko Imamoto. The network helps show where Haruhiko Imamoto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Haruhiko Imamoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | [A Case of Bullous Pemphigoid after Combined Chemotherapy of Durvalumab, Gemcitabine and Cisplatin for Intrahepatic Cholangiocarcinoma]. | 2025 | 0 |
| 2 | 2021 | 1 | |
| 3 | 2020 | 7 | |
| 4 | 2017 | 0 | |
| 5 | 2017 | 56 | |
| 6 | 2013 | 42 | |
| 7 | 2013 | 73 | |
| 8 | 2012 | 7 | |
| 9 | 2012 | 31 | |
| 10 | 2011 | 28 | |
| 11 | 2011 | 0 | |
| 12 | 2011 | 114 | |
| 13 | 2010 | 4 | |
| 14 | 2010 | 92 | |
| 15 | 2010 | 12 | |
| 16 | 2009 | 33 | |
| 17 | 2008 | 24 | |
| 18 | 2006 | 16 | |
| 19 | 1990 | 159 | |
| 20 | 1989 | 1 |
About Haruhiko Imamoto
Haruhiko Imamoto is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine and Surgery, having authored 70 papers that have together received 1.4k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (37 papers), Gastrointestinal Tumor Research and Treatment (21 papers), Esophageal Cancer Research and Treatment (15 papers), Metastasis and carcinoma case studies (13 papers), Intraperitoneal and Appendiceal Malignancies (12 papers), Esophageal and GI Pathology (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers) and Lung Cancer Treatments and Mutations (6 papers). The work is most often cited by research in Gastroenterology (341 citations), Pulmonary and Respiratory Medicine (893 citations) and Surgery (842 citations). Haruhiko Imamoto has collaborated with scholars based in Japan, Singapore and Romania. Frequent co-authors include Motohiro Imano, Hitoshi Shiozaki, Takushi Yasuda, Masayuki Shinkai, Ying‐Feng Peng, Hiroshi Furukawa, Atsushi Yasuda, Atsushi Nashimoto, Yasuhiro Kodera and Hironori Ishigami. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.